Skip to content

DTx 101 Series 

Part Three: Tackling Digital Therapeutic Reimbursement

Our four-part DTx 101 Series covers various aspects of the Digital Therapeutics (DTx) market to gain a better understanding into defining DTx and market trends, DTx business models, reimbursement considerations, and US FDA regulatory approaches.

Part 3 of our DTx 101 Series covers the approaches and options for DTx companies to secure reimbursement from payers and health systems with a better understanding of the requirement from Centers for Medicare and Medicaid Services (CMS).

Fill out the form to download Part 3 -Tackling Digital Therapeutic Reimbursement